The results of univariate Cox survival analyses revealed that younger age, IDH mutation status, chemotherapy, radiotherapy, and low Loxl1 expression were protective variables, which translated into an extended survival period for patients with GBM (Fig. 4B). The gene discussed is LOXL1; the disease is glioblastoma.